BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17434821)

  • 1. Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
    Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
    J Chemother; 2007 Apr; 19(2):140-5. PubMed ID: 17434821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms.
    Strateva T; Ouzounova-Raykova V; Markova B; Todorova A; Marteva-Proevska Y; Mitov I
    J Med Microbiol; 2007 Jul; 56(Pt 7):956-963. PubMed ID: 17577062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients.
    Mirsalehian A; Feizabadi M; Nakhjavani FA; Jabalameli F; Goli H; Kalantari N
    Burns; 2010 Feb; 36(1):70-4. PubMed ID: 19524369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
    Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
    Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran.
    Shahcheraghi F; Nikbin VS; Feizabadi MM
    Microb Drug Resist; 2009 Mar; 15(1):37-9. PubMed ID: 19265477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
    Triantafilo V; Fica A; Silva M; Thompson L
    Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia.
    Al-Agamy MH; Shibl AM; Tawfik AF; Elkhizzi NA; Livermore DM
    J Chemother; 2012 Apr; 24(2):97-100. PubMed ID: 22546765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran.
    Jabalameli F; Mirsalehian A; Sotoudeh N; Jabalameli L; Aligholi M; Khoramian B; Taherikalani M; Emaneini M
    Burns; 2011 Nov; 37(7):1202-7. PubMed ID: 21703769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PER-1- and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey.
    Aktaş Z; Poirel L; Salcioğlu M; Ozcan PE; Midilli K; Bal C; Anğ O; Nordmann P
    Clin Microbiol Infect; 2005 Mar; 11(3):193-8. PubMed ID: 15715716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Martins AF; Zavascki AP; Gaspareto PB; Barth AL
    Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.